myHealthbox
Idħol
Foster 100/6 micrograms per actuation pressurised inhalation solution
Bulgarija -
Bulgaru -
Изпълнителна агенция по лекарствата
Ixtrih issa
Fuljett ta 'informazzjoni
(PIL)
17-01-2022
Karatteristiċi tal-prodott
(SPC)
16-03-2020
Ingredjent attiv:
Beclometasone дипропионат, Формотерола фумарата дигидрат
Disponibbli minn:
Chiesi Pharmaceuticals GmbH
Kodiċi ATC:
R03AK7
INN (Isem Internazzjonali):
Beclometasone dipropionate, Formoterol fumarate dihydrate
Dożaġġ:
100/6 micrograms per actuation pressurised inhalation solution
Sommarju tal-prodott:
Foster, 100/6 micrograms per actuation pressurised inhalation solution x 1 x 120
Numru ta 'awtorizzazzjoni:
20080070
Data ta 'l-awtorizzazzjoni:
2015-09-24
Aqra d-dokument sħiħ
Fuljett ta 'informazzjoni preview
Aqra d-dokument sħiħ
Karatteristiċi tal-prodott preview
Similar products
Ingredjent attiv
Beclometasone дипропионат, Формотерола фумарата дигидрат
Kodiċi ATC
R03AK7
Marketed minn
Chiesi Pharmaceuticals GmbH
INN (Isem Internazzjonali)
Beclometasone dipropionate, Formoterol fumarate dihydrate
Fittex twissijiet relatati ma 'dan il-prodott
Twissijiet
Foster 100/6 micrograms per Beclometasone дипропионат, Формотерола фумарата dipropionate, Formoterol fumarate dihydrate
Ara l-istorja tad-dokumenti
L-istorja tad-dokumenti
Foster 100/6 micrograms per actuation pressurised inhalation solution
Aqsam din l-informazzjoni